Living with epilepsy is a lot more complex than people may think.
If you’re still having seizures despite medication, it may be time to explore the RNS® System.
Take this 2-minute quiz to see if a personalized treatment option may be right for you: https://t.co/fUfVj36ch8
Attending ASSFN? Join NeuroPace for our Breakfast Symposium on Mon, June 1 at 7 AM.
We’ll discuss Responsive Thalamic Neuromodulation, 18-month Nautilus data, & our LGS Feasibility Study with Drs. Rolston, Richardson, & Morrell.
Space is limited—RSVP here: https://t.co/A5NLRf4lsg
CAUTION - Investigational device. Limited by United States law to investigational use for Idiopathic Generalized Epilepsy (IGE) and Lennox-Gastaut Syndrome (LGS).
Rx Only. The RNS® System is an adjunctive therapy for adults with refractory, partial onset seizures with no
more than 2 epileptogenic foci. See important safety information at https://t.co/phw9TTn5jG
ASSFN Fellows! Join NeuroPace for an exclusive networking dinner on Sat, May 30 at 6:00 PM.
Connect with colleagues and discuss strategies for building your neuromodulation practice post-fellowship.
This event is limited to just 30 seats. Reserve yours here: https://t.co/ooy6egGYdn
Invite Link:
https://t.co/ooy6egGYdn
Registration Link:
https://t.co/cIMt76FTcg
We are on the floor at ASSFN! Stop by Booth #107 to connect with the clinical team, and learn more about the RNS® System for drug-resistant focal epilepsy.
See you there!
Rx Only. The RNS® System is an adjunctive therapy for adults with refractory, partial onset seizures with no more than 2 epileptogenic foci. See important safety information at https://t.co/phw9TTn5jG
The RNS® System Post-Approval Study, now published in @GreenJournal, reveals sustained long-term outcomes for drug-resistant focal epilepsy.
See the full study results: https://t.co/tvLXuhv06k
RNS System Safety Info: https://t.co/StMsbqNwyY
In The Pitt Season 2 finale, Dr. Al-Hashimi's "neuromodulation device which can sense and stop the seizures almost immediately" — that’s a real description of how the RNS® System from NeuroPace works.
#RNSSystem#Epilepsy#NeuroPace#ThePitt
RNS System Safety Info: https://t.co/phw9TTn5jG
https://t.co/I2Q3I6a5wW
#Seizures can affect everyday independence, including the ability to drive. 🚗 The RNS® System stops seizures at the source, helping you get back to more of life’s everyday moments.*➡️ Take the quiz to see if the RNS System might be right for you: https://t.co/oL16fzR52D
Safety Info: https://t.co/phw9TTn5jG
*Every person’s seizures are different and individual results will vary.
#epilepsy #seizures #epilepsyawareness
Q1 2026 results: $22.1M in revenue, RNS System revenue up ~20% YoY 📈; Full year guidance raise; Strong operating leverage.
Continued RNS System growth and a clear roadmap ahead across market, clinical, and product development.
Full release + webcast → https://t.co/8fRgD6JRWD
#NPCE #NeuroPace #MedTech #Epilepsy
Epilepsy treatment is not one size fits all. If your anti-seizure meds are not working, it may be time to learn about a different treatment option. Join our free webinar to ask an #epilepsy specialist during our Q&A session: https://t.co/ghnYcIQt7M
🗓️Free webinar: Tue 5/12, at 5pm PT/8pm ET
Safety Info: https://t.co/phw9TTn5jG
Attending ASSFN? Join NeuroPace for our Breakfast Symposium on Mon, June 1 at 7 AM.
We’ll discuss Responsive Thalamic Neuromodulation, 18-month Nautilus data, & our LGS Feasibility Study with Drs. Rolston, Richardson, & Morrell.
Space is limited—RSVP here: https://t.co/A5NLRf4lsg
CAUTION - Investigational device. Limited by United States law to investigational use for Idiopathic Generalized Epilepsy (IGE) and Lennox-Gastaut Syndrome (LGS).
Rx Only. The RNS® System is an adjunctive therapy for adults with refractory, partial onset seizures with no
more than 2 epileptogenic foci. See important safety information at https://t.co/phw9TTn5jG
ASSFN Fellows! Join NeuroPace for an exclusive networking dinner on Sat, May 30 at 6:00 PM.
Connect with colleagues and discuss strategies for building your neuromodulation practice post-fellowship.
This event is limited to just 30 seats. Reserve yours here: https://t.co/ooy6egGYdn
Invite Link:
https://t.co/ooy6egGYdn
Registration Link:
https://t.co/cIMt76FTcg
#NursesWeek To every nurse supporting people with epilepsy—you make a difference every day.
Thank you for the compassion, care, and commitment. 🩺💜
#ThankYouNurses#EpilepsyCare
Long-term efficacy is a critical goal in treating drug-resistant epilepsy. See the newly published 3-year results from the RNS® System Post-Approval Study.
Review the full study here: https://t.co/tvLXuhv06k
RNS System Safety Info: https://t.co/StMsbqNwyY